<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488291</url>
  </required_header>
  <id_info>
    <org_study_id>IPMCH</org_study_id>
    <nct_id>NCT02488291</nct_id>
  </id_info>
  <brief_title>Effect of Sufentanil and Ropivacaine</brief_title>
  <official_title>Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor
      in primiparas so as to decrease perinatal complications of analgesia labor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective study of 120 full-term parturients receiving labor analgesia were randomly
      assigned into 2 groups: the 0.5Sufen group (N=60), the 0.25Sufen group (N=60).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS(visual analog pain score)</measure>
    <time_frame>1 year</time_frame>
    <description>comparison with two groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Anesthesia Complications</condition>
  <arm_group>
    <arm_group_label>0.5 sufentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5µg/ml sufentanil, 0.1% ropivacaine for 6ml/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.25 sufentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.25µg/ml sufentanil, 0.1% ropivacaine for 6ml/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25 sufentanil</intervention_name>
    <description>with different dosage</description>
    <arm_group_label>0.25 sufentanil</arm_group_label>
    <other_name>opiods</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5µg/ml sufentanil</intervention_name>
    <description>0.5µg/ml sufentanil</description>
    <arm_group_label>0.5 sufentanil</arm_group_label>
    <other_name>opiods</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.1% ropivacaine</intervention_name>
    <description>0.1% ropivacaine</description>
    <arm_group_label>0.5 sufentanil</arm_group_label>
    <arm_group_label>0.25 sufentanil</arm_group_label>
    <other_name>Local Anesthetics</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients had regular prenatal examinations at the outpatient clinic;

          2. They were between 25 to 35 years of age)

          3. They had a gestational age ≥37 weeks and &lt; 42 weeks;

          4. They had an estimated fetal weight ≥ 2,500 g and &lt; 4,200 g.

        Exclusion Criteria:

          -  a history of spinal surgery,

          -  platelet count ＜100×109 /L ,

          -  coagulation disorder,

          -  sensorimotor disorder of lower extremity,

          -  leg pain,

          -  puncture point infection,

          -  heart disease history,

          -  pulmonary disease,

          -  liver and renal function disorder and

          -  a history of neuropsychiatry drugs.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeyong Yang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University, Shanghai Jiaotong University</affiliation>
  </overall_official>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>December 7, 2016</last_update_submitted>
  <last_update_submitted_qc>December 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Zeyong Yang</investigator_full_name>
    <investigator_title>Hospital</investigator_title>
  </responsible_party>
  <keyword>Epidural</keyword>
  <keyword>Analgesia labor</keyword>
  <keyword>Perinatal</keyword>
  <keyword>anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

